Skip to search formSkip to main contentSkip to account menu

GP 140

Known as: GP-140, GP140, glycoprotein 140 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
ABSTRACT A phase I safety and immunogenicity study investigated South African AIDS Vaccine Initiative (SAAVI) HIV-1 subtype C… 
Highly Cited
2011
Highly Cited
2011
We conducted a phase 1 double-blind randomised controlled trial (RCT) of a HIV-1 envelope protein (CN54 gp140) candidate vaccine… 
2003
2003
ABSTRACT We have studied the induction of neutralizing antibodies by in vivo expression of the human immunodeficiency virus type… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT Four groups of cats, each containing four animals, were immunized at 0, 3, and 6 weeks with minimalistic immunogenic… 
Highly Cited
1996
Highly Cited
1996
Human antibody responses, or versions thereof, can be cloned as phage display libraries. In vaccine evaluation, the possibility… 
Highly Cited
1985
Highly Cited
1982
Highly Cited
1982
The detergent-insoluble matrix of cultured human fibroblasts contains cytoskeletal and nuclear components, as well as two major…